Title : Association of systemic inflammation and lipid biomarkers with cognitive decline at older patients
Abstract:
Early identification of risk factors for cognitive impairment is essential for prevention and therapeutic management. Normal aging comes with some cognitive decline, but when these changes become significant they may indicate the existence of a cognitive disorder. Systemic inflammation is in a close causal relationship with cognitive decline (we studied Systemic Immune-Inflammatory Index -SII, Aggregate Index of Systemic Inflammation –AISI, System Inflammation Response Index –SIRI, NHR, PHR, RNL). Atherogenic status is also a major risk factor for the progression of cognitive deficit (we studied atherogenic index -AI, atherogenic coefficient –AC, TyG index –TyG, Castelli risk index I –CI, Castelli risk II-CII and CholIndex –ChI). The purpose of this study was to identify if immunoinflammatory and atherogenic indices are associated with decline in cognitive function and could be useful biomarkers in prevention and early diagnosis.
Methods: Pilot study was conducted on 74 patients (over 70 years) of which 42 with major cognitive deficit vs. 32 control patients. AI was calculated as log(TG/HDL), TyG as ln(TGxglucose/2), ChI as LDL-HDL, CRI as cholesterol/HDL, CRII as LDL/HDL, AC as CT-HDL/HDL. SII was calculated as neutrophil x platelet/lymphocyte; AISI as neutrophil x monocyte/lymphocyte; SIRI as neutrophil x monocyte x platelet/lymphocyte, NHR as neutrophil /HDL, PHR as platelets /HDL, RNL as neutrophil /lymfocyte. Tools for screening cognitive changes and determining their severity were: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Clock Drawing Test.
Results: Data revealed at major cognitive deficit patients high levels of atherogenic indices: AC (2.34 vs. 1.86; p<0.01); CI (3.34 vs. 2.86; p<0.01); CII (1.94 vs. 1.57; p<0.01); AI (0.24 vs. 0.15; p<0.05); TyG (8.52 vs. 8.3; p<0.01); ChI (2.84 vs. 1.91; p<0.05) vs. control. Likewise high levels of immunoinflammatory markers: RNL (2.54 vs. 1.9; p<0.05); NHR (0.07 vs. 0.04; p<0.001); PHR (4.56 vs. 3.93; p<0.05); IIS (617.36 vs. 468.65; p<0.05); SIRI (1.06 vs. 0.78; p<0.01); AISI (268.01 vs. 198.33; p<0.01) vs. control. Linear regression equation shows positive correlation between SIRI and AC, CI, CII (p<0.05) also IA with NHR, PHR, MHR (p<0.001).
Conclusions: Currently studies on the influence of inflammation and atherogenic process on cognitive decline are contradictory and it is not clear whether these processes cause cognitive deficits due to aging or are a result of cognitive problems. The results of our study shows that increased atherogenicity and inflammatory immune response are clearly correlated with cognitive decline. Therefore, potential biomarkers studied could be used to evaluate the risk and to estimate the progression of cognitive decline.
